Synchronicity Pharma was founded on pioneering work by world-leading experts in the field of circadian biology. Synchronicity is developing novel therapeutics for the treatment of sleep-wake disorders associated with neurodivergence and for difficult-to-treat cancers.
| Website | http://synchronicitypharma.com |
| Revenue | $2 million |
| Employees | 4 (2 on RocketReach) |
| Address | 750 Battery St Ste 400, San Francisco, California 94111, US |
| Phone | +1 650-235-4140 |
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Competitors | Shuttle Pharmaceuticals, Inc., CILcare, Encysive Pharmaceuticals, Immunohelix, Escend Pharmaceuticals , Inc. (view competitors) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Synchronicity Pharma employee's phone or email?
Synchronicity Pharma Questions
The Synchronicity Pharma annual revenue was $2 million in 2026.
Remy Sukhija is the CEO of Synchronicity Pharma.
2 people are employed at Synchronicity Pharma.
Synchronicity Pharma is based in San Francisco, California.
The NAICS codes for Synchronicity Pharma are [325, 3254, 32, 32541].
The SIC codes for Synchronicity Pharma are [283, 28].
Top Synchronicity Pharma Employees
-
Remy Sukhija
Chief Executive Officer at Synchronicity Pharma
New York, NY, US23 -
35+
